Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pain × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Liver Neoplasms 5 Carcinoma, Hepatocellular 5 Neoplasm Metastasis 3 Biliary Tract Neoplasms 2 Squamous Intraepithelial Lesions 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteosarcoma 1 Lung Neoplasms 1 Hepatitis B, Chronic 1 HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1 Esophageal Squamous Cell Neoplasia (ESCN) 1 Esophageal Squamous Cell Carcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adrenal Gland Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Fentanyl 7 nabiximols 6 Morphine 6 Hydromorphone 6 Tapentadol 5 Prednisone 3 Methadone 3 Calcium Dobesilate 3 Acetaminophen 3 cabozantinib 2 Surveys and Questionnaires 2 Sugars 2 Radiotherapy 2 Radiosurgery 2 Pregabalin 2 Pain Management 2 Oxycodone 2 Minocycline 2 Letrozole 2 Ketamine 2 Ibuprofen 2 Duloxetine Hydrochloride 2 Diclofenac 2 Dexamethasone 2 Cryosurgery 2 Calcium Gluconate 2 Calcium 2 Analgesia 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tandutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00712712 2025-08-29

MEDOR

Institut Bergonié

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡